Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Defective GNAS imprinting due to splice site variants in pseudohypoparathyroidism type 1B
Yorihiro Iwasaki, … , Murat Bastepe, Harald Jüppner
Yorihiro Iwasaki, … , Murat Bastepe, Harald Jüppner
Published September 2, 2025
Citation Information: JCI Insight. 2025;10(19):e194754. https://doi.org/10.1172/jci.insight.194754.
View: Text | PDF
Research Letter Endocrinology Genetics

Defective GNAS imprinting due to splice site variants in pseudohypoparathyroidism type 1B

  • Text
  • PDF
Abstract

Authors

Yorihiro Iwasaki, Monica Reyes, Arnaud Molin, Mari Muurinen, Marie-Laure Kottler, Murat Bastepe, Harald Jüppner

×

Figure 1

Exon H splice donor site disruption as a previously undescribed cause of AD-PHP1B.

Options: View larger image (or click on image) Download as PowerPoint
Exon H splice donor site disruption as a previously undescribed cause of...
(A) Loss of methylation (LOM) can occur at all maternal GNAS DMRs, but LOM at the A/B DMR alone is sufficient to reduce Gsα expression, thus causing PHP1B. Maternal exon H transcripts establish all maternal DMRs during oogenesis, while maternal NESP transcripts facilitate postzygotic remethylation of the A/B and AS2 DMRs. (B) Methylation at GNAS DMRs (%), microsatellite analyses, and the exon H splice donor site (exHss) variant in kindred 285. (C) The exHss variant is located in 285/I-2 on the paternal allele; nucleotide sequence analysis of PCR amplicons of non-digested (top) and HpaII-digested genomic DNA (bottom). (D) Minigene reporter assay revealed in hESCs reduced H exon–derived transcription due to SNVs at the exHss. ****P < 0.0001 by 1-way ANOVA with Tukey’s post hoc test. (E) Disruption of the maternal exHss by introducing 13-bp or 8-bp deletions into hESCs through CRISPR/Cas9. (F) RT-PCR assessing exon H–derived transcripts (left) and schematic presentation of the cryptic splice site (right). Arrows indicate PCR primers (see Supplemental Methods for details). (G) qRT-PCR assessing exon H– and Gsα-derived transcript levels. ***P < 0.001 by 1-sample t test. NS, nonsignificant. (H) Top: The establishment of maternal GNAS methylation imprints occurs during oogenesis and postzygotically. Bottom: Disruption of the exon H splice donor site attenuates transcription from this exon, thus preventing establishment of maternal methylation during oogenesis and leading postzygotically to the Cat1-PHP1B epigenotype. Data are shown as mean ± SEM of 3 independent experiments (D) or independent clones (G).

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts